|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate 显示文摘 | Weinblatt M E Kremer J M Bankhurst A D | 1999 | N Engl J Med1999，340，4： | 1 |
| 2 | Etanercept and methotrexate combination therapy显示文摘 | | 1999 | Clin Exp Rheumatol1999，1718，： | 1 |
| 3 | A trial of etanereept,a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate显示文摘 | Weinblatt M E Kremer J M Bankhurst A D Bulpitt K J Fleischmann R M Fox R I | 1999 | N Engl J Med1999，340，： | 1 |
| 4 | A trial of etaner-cept, a recom-binant tumor necrosis factor recepor: Fc fusionprotein, inpatients with rheumatoid arthritis receiving methotrexate显示文摘 | Weinblatt M E Kremer J M Bankhurst A D | 1999 | N Engl JMed1999，340，4： | 1 |
| 5 | A trial of etanercept,a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexate 显示文摘 | Weinblatt ME Kremer JM Bankhurst AD | 1999 | N Engl J Med1999，340，4： | 1 |
| 6 | Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations显示文摘 | Kremer JM Weinblatt ME Bankhurst AD | 2003 | Arthritis Rheum2003，48，6： | 1 |
| 7 | A trial of Etanerc ept,a re combinant tumor necrosis factor receptor: Fc fusion protein, in patients with RA receiving MTX显示文摘 | Kremer JM Bankhurst AD | 1999 | New Eng J Med,1999，340，4： | 1 |
| 8 | 显示文摘 | Weinblatt ME Kremer JM Bankhurst AD | 1999 | N Engl J Med1999，340，： | 1 |
| 9 | A trial of etanercept, a recombinant tumor necrosis factor receptor显示文摘 | WEINBLASTT M E KREMER J M BANKHURST A D | 1999 | N Engl J Med1999，340，： | 1 |
| 10 | A trial of Etanercept,a recombinant tumor necrosis faetor recepto: Fcfusion protein,in patients with RA receiving MTX显示文摘 | Weinblat t M E Kremer J M Bankhurst A D etal | 1999 | New Eng J Med1999，340，4： | 1 |
| 11 | A trial of etanercept,a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexate显示文摘 | Weinblatt ME Kremer JM Bankhurst AD | 1999 | N Engl J Med1999，340，： | 1 |
| 12 | A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate显示文摘 | Weinblatt ME Kremer JM Bankhurst AD | 1999 | N Engl J Med1999，340，4： | 1 |
| 13 | Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer anti- bacterial activity显示文摘 | Garcia-Penarrubia P Bankhurst AD Koster FT | 1989 | J Exp Med1989，170，2： | 1 |
| 14 | Etanereept added to the background methotrexate therapy in patients with rheumatoid ar- thritis : eontimued observation 显示文摘 | Keremer JM Weinblatt ME Bankhurst AD | 2003 | Arthritis Rheum2003，48，6： | 1 |
| 15 | A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexate显示文摘 | Weinblatt ME Kremer JM Bankhurst AD | 1999 | N Eng J Med1999，340，4： | 1 |
| 16 | Etanercept added to background methotrexate therapy in patients with rheunmtoid arthritis: continued observations显示文摘 | Kremer JM Weinblatt ME Bankhurst AD | 2003 | Arthritis Rhetan2003，48，6： | 1 |
| 17 | Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis显示文摘 | McChesney MB Bankhurst AD | 1986 | Ann Rheum Dis1986，45，7： | 1 |
| 18 | A trial of etanercept,a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexate显示文摘 | WEINBLATT ME KREMER JM BANKHURST AD | 1999 | N Engl J Med1999，340，4： | 1 |
| 19 | Etanercept added to the background methotrexate therapy in patients with rheumatoid arthritis:continued observations显示文摘 | KREMER JM WEINBLATT ME BANKHURST AD | 2003 | Arthritis Rheum2003，48，6： | 1 |
| 20 | Cigarette smoking and disease activity in systemic lupus erythematosus显示文摘 | Ghaussy NO Sibbitt W Jr Bankhurst AD | 2003 | J Rheuma- tol2003，30，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员